WEST PALM BEACH, Fla, April 19, 2018 -- Rennova Health, Inc. (OTCQB: RNVA), (OTCQB: RNVAW) (“Rennova” or the “Company”), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers that recently announced the acquisition of its second Rural Hospital, today announces that it expects to file its full year audited financial statements for 2017 (on Form 10-K) and accompanying press release after market close on Monday April 23, 2018.
“We had previously disclosed our expectation to file this information on Tuesday April 17, 2018 but completion of our audited financial statements has taken a few days longer than expected, caused mainly by the addition of our new Hospital sector business and separation of discontinued businesses,” stated Seamus Lagan, President and Chief Executive Officer. “We look forward to disclosing our results and believe they reflect the progress we have made building our business through 2017.”
About Rennova Health, Inc.
Rennova provides industry-leading diagnostics and supportive software solutions to healthcare providers, delivering an efficient, effective patient experience and superior clinical outcomes. Through an ever-expanding group of strategic brands that work in unison to empower customers, we are creating the next generation of healthcare. For more information, please visit www.rennovahealth.com.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Additional information concerning these and other risk factors are contained in the Company’s most recent filings with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.
Contacts:
Rennova Health
Sebastien Sainsbury, 561-666-9818
[email protected]
# # #


Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Capital One Says AML Review Led to Closure of Trump Organization Accounts
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Japan Earthquake Disrupts Auto and Chip Supply Chains
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Same sparkle, different story: how lab-grown diamonds are transforming the market
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 



